Skip to main content

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1165408 Boston, MA

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$152,905,794
+$143,771,100 QoQ
Shares Held
1,722,300
+182.3% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#18
of 260 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. SYRE ranks #6 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 SYRE
Spyre Therapeutics, Inc.
This page
1,722,300 $152,905,794

All Filings in SYRE

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $152,905,794 1,722,300
2025-06-30 $9,134,694 610,200
2025-03-31 $12,959,632 803,200
2024-12-31 $23,978,400 1,030,000
2024-09-30 $31,027,550 1,055,000
2024-06-30 $27,093,182 1,152,411
2024-03-31 $41,920,236 1,105,200
2023-12-31 $21,520,000 1,000,000